1.Keefe RS, Bilder RM, Davis SM, Harvey PD, Palmer BW, Gold JM, Meltzer HY, Green MF, Capuano G, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, Davis CE, Hsiao JK, Lieberman JA: Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE trial. Arch Gen Psychiatry 2007; 64:633–647
2.Goff DC, Lamberti JS, Leon AC, Green MF, Miller AL, Patel J, Manschreck T, Freudenreich O, Johnson SA: A placebo-controlled add-on trial of the ampakine, CX516, for cognitive deficits in schizophrenia. Neuropsychopharmacology 2008; 33:465–472
3.Keefe RS, Malhotra AK, Meltzer HY, Kane JM, Buchanan RW, Murthy A, Sovel M, Li C, Goldman R: Efficacy and safety of donepezil in patients with schizophrenia or schizoaffective disorder: significant placebo/practice effects in a 12-week, randomized, double-blind, placebo-controlled trial. Neuropsychopharmacology 2008; 33:1217–1228
4.Buchanan RW, Conley RR, Dickinson D, Ball MP, Feldman S, Gold JM, McMahon RP: Galantamine for the treatment of cognitive impairments in people with schizophrenia. Am J Psychiatry 2008; 165:82–89
5.Chouinard S, Stip E, Poulin J, Melun JP, Godbout R, Guillem F, Cohen H: Rivastigmine treatment as an add-on to antipsychotics in patients with schizophrenia and cognitive deficits. Curr Med Res Opin 2007; 23:575–583
6.Twamley EW, Jeste DV, Bellack AS: A review of cognitive training in schizophrenia. Schizophr Bull 2003; 29:359–382
7.McGurk SR, Twamley EW, Sitzer DI, McHugo GJ, Mueser KT: A meta-analysis of cognitive remediation in schizophrenia. Am J Psychiatry 2007; 164:1791–1802
8.Heinrichs RW, Zakzanis KK: Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology 1998; 12:426–445
9.Green MF: What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry 1996; 153:321–330
10.Green MF, Kern RS, Braff DL, Mintz J: Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the “right stuff”? Schizophr Bull 2000; 26:119–136
11.Evans JD, Bond GR, Meyer PS, Kim HW, Lysaker PH, Gibson PJ, Tunis S: Cognitive and clinical predictors of success in vocational rehabilitation in schizophrenia. Schizophr Res 2004; 70:331–342
12.Brekke JS, Long JD, Nesbitt N, Sobel E: The impact of service characteristics on functional outcomes from community support programs for persons with schizophrenia: a growth curve analysis. J Consult Clin Psychol 1997; 65:464–475
13.Bell MD, Bryson G: Work rehabilitation in schizophrenia: does cognitive impairment limit improvement? Schizophr Bull 2001; 27:269–279
14.McGurk SR, Mueser KT: Cognitive functioning, symptoms, and work in supported employment: a review and heuristic model. Schizophr Res 2004; 70:147–173
15.Weiss AP, Heckers S: Neuroimaging of declarative memory in schizophrenia. Scand J Psychol 2001; 42:239–250
16.Ragland JD, Gur RC, Valdez J, Turetsky BI, Elliott M, Kohler C, Siegel S, Kanes S, Gur RE: Event-related fMRI of frontotemporal activity during word encoding and recognition in schizophrenia. Am J Psychiatry 2004; 161:1004–1015
17.Kasai K, Nakagome K, Itoh K, Koshida I, Hata A, Iwanami A, Fukuda M, Kato N: Impaired cortical network for preattentive detection of change in speech sounds in schizophrenia: a high-resolution event-related potential study. Am J Psychiatry 2002; 159:546–553
18.Light GA, Swerdlow NR, Braff DL: Preattentive sensory processing as indexed by the MMN and P3a brain responses is associated with cognitive and psychosocial functioning in healthy adults. J Cogn Neurosci 2007; 19:1624–1632
19.Kawakubo Y, Kasai K, Kudo N, Rogers MA, Nakagome K, Itoh K, Kato N: Phonetic mismatch negativity predicts verbal memory deficits in schizophrenia. Neuroreport 2006; 17:1043–1046
20.Leitman DI, Hoptman MJ, Foxe JJ, Saccente E, Wylie GR, Nierenberg J, Jalbrzikowski M, Lim KO, Javitt DC: The neural substrates of impaired prosodic detection in schizophrenia and its sensorial antecedents. Am J Psychiatry 2007; 164:474–482
21.Javitt DC, Shelley A, Ritter W: Associated deficits in mismatch negativity generation and tone matching in schizophrenia. Clin Neurophysiol 2000; 111:1733–1737
22.Light GA, Braff DL: Mismatch negativity deficits are associated with poor functioning in schizophrenia patients. Arch Gen Psychiatry 2005; 62:127–136
23.Merzenich MM: Cortical plasticity: from synapse to maps. Annual Rev Neurosci 1998; 21:149–186
24.Koch K, Wagner G, Nenadic I, Schachtzabel C, Roebel M, Schultz C, Axer M, Reichenbach JR, Sauer H, Schlosser RG: Temporal modeling demonstrates preserved overlearning processes in schizophrenia: an fMRI study. Neuroscience 2007; 146:1474–1483
25.Kern RS, Green MF, Wallace CJ: Declarative and procedural learning in schizophrenia: a test of the integrity of divergent memory systems. Cogn Neuropsychiatry 1997; 2:39–50
26.Wexler BE, Hawkins KA, Rounsaville B, Anderson M, Sernyak MJ, Green MF: Normal neurocognitive performance after extended practice in patients with schizophrenia. Schizophr Res 1997; 26:173–180
27.Wexler BE, Anderson M, Fulbright RK, Gore JC: Preliminary evidence of improved verbal working memory performance and normalization of task-related frontal lobe activation in schizophrenia following cognitive exercises. Am J Psychiatry 2000; 157:1694–1697
28.Danion J-M, Meulemans T, Kauffmann-Muller F, Vermaat H: Intact implicit learning in schizophrenia. Am J Psychiatry 2001; 158:944–948
29.Mahncke HW, Bronstone A, Merzenich MM: Brain plasticity and functional losses in the aged: scientific bases for a novel intervention. Prog Brain Res 2006; 157:81–109
30.Kallstrand J, Montnemery P, Nielzen S, Olsson O: Auditory masking experiments in schizophrenia. Psychiatry Res 2002; 113:115–125
31.Deci EL, Eghrari H, Patrick BC, Leone DR: Facilitating internalization: the self-determination theory perspective. J Pers 1994; 62:119–142
32.Ryan RM, Koestner R, Deci EL: Ego-involved persistence: when free-choice behavior is not intrinsically motivated. Motiv Emot 1991; 15:185–205
33.Kay SR, Fiszbein A, Opler LA: The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull 1987; 13:261–276
34.Bilker WB, Brensinger C, Kurtz MM, Kohler C, Gur RC, Siegel SJ, Gur RE: Development of an abbreviated schizophrenia quality of life scale using a new method. Neuropsychopharmacology 2003; 28:773–777
35.Nuechterlein KH, Green MF: MATRICS Consensus Cognitive Battery Manual. Los Angeles, MATRICS Assessment, 2006
36.Keefe RS, Goldberg TE, Harvey PD, Gold JM, Poe MP, Coughenour L: The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery. Schizophr Res 2004; 68:283–297
37.Wible CG, Kubicki M, Yoo S-S, Kacher DF, Salisbury DF, Anderson MC, Shenton ME, Hirayasu Y, Kikinis R, Jolesz FA, McCarley RW: A functional magnetic resonance imaging study of auditory mismatch in schizophrenia. Am J Psychiatry 2001; 158:938–943
38.Merzenich MM: Cortical plasticity contributing to child development, in Mechanisms in Cognitive Development. Edited by McClelland J, Siegler R. Rahway, NJ, Lawrence Erlbaum, 2001, pp 67–96
39.Fisher M, Holland C, Subramaniam K, Vinogradov S: Neuroplasticity-based cognitive training in schizophrenia: an interim report on the effects 6 months later. Schizophr Bull, March 5, 2009, Epub ahead of print